Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-009306
Filing Date
2023-03-28
Accepted
2023-03-28 17:04:58
Documents
57
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1505088
2 ex4-7.htm EX-4.7 53109
3 ex10-14.htm EX-10.14 31102
4 ex31-1.htm EX-31.1 17482
5 ex31-2.htm EX-31.2 17869
6 ex32-1.htm EX-32.1 7436
7 ex32-2.htm EX-32.2 8868
  Complete submission text file 0001493152-23-009306.txt   4971998

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE murfu-20221231.xsd EX-101.SCH 30738
9 XBRL CALCULATION FILE murfu-20221231_cal.xml EX-101.CAL 36987
10 XBRL DEFINITION FILE murfu-20221231_def.xml EX-101.DEF 184291
11 XBRL LABEL FILE murfu-20221231_lab.xml EX-101.LAB 249765
12 XBRL PRESENTATION FILE murfu-20221231_pre.xml EX-101.PRE 225559
51 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 526985
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
Murphy Canyon Acquisition Corp. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41245 | Film No.: 23770454
SIC: 2834 Pharmaceutical Preparations